Martin DB - Search Results

1

Enhancing Vaccine Safety Capacity Globally: A Lifecycle Perspective.

Chen RT, Shimabukuro TT, Martin DB, Zuber PL, Weibel DM, Sturkenboom M. Chen RT, et al. Among authors: martin db. Am J Prev Med. 2015 Dec;49(6 Suppl 4):S364-76. doi: 10.1016/j.amepre.2015.09.009. Am J Prev Med. 2015. PMID: 26590436 Review.

2

Enhancing vaccine safety capacity globally: A lifecycle perspective.

Chen RT, Shimabukuro TT, Martin DB, Zuber PL, Weibel DM, Sturkenboom M. Chen RT, et al. Among authors: martin db. Vaccine. 2015 Nov 27;33 Suppl 4(0 4):D46-54. doi: 10.1016/j.vaccine.2015.06.073. Epub 2015 Oct 1. Vaccine. 2015. PMID: 26433922 Free PMC article. Review.

3

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).

Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Shimabukuro TT, et al. Vaccine. 2015 Aug 26;33(36):4398-405. doi: 10.1016/j.vaccine.2015.07.035. Epub 2015 Jul 22. Vaccine. 2015. PMID: 26209838 Free PMC article. Review.

4

Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the vaccine adverse event reporting system.

Leroy Z, Broder K, Menschik D, Shimabukuro T, Martin D. Leroy Z, et al. Vaccine. 2012 Mar 2;30(11):2020-3. doi: 10.1016/j.vaccine.2011.12.042. Vaccine. 2012. PMID: 22361303

5

In the heat of a signal: responding to a vaccine safety signal for febrile seizures after 2010-11 influenza vaccine in young children, United States.

Broder KR, Martin DB, Vellozzi C. Broder KR, et al. Among authors: martin db. Vaccine. 2012 Mar 2;30(11):2032-4. doi: 10.1016/j.vaccine.2011.12.040. Vaccine. 2012. PMID: 22361305 No abstract available.

6

Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010.

Moro PL, Arana J, Cano M, Menschik D, Yue X, Lewis P, Haber P, Martin D, Broder K. Moro PL, et al. Clin Infect Dis. 2012 Jun;54(11):1608-14. doi: 10.1093/cid/cis256. Epub 2012 Mar 22. Clin Infect Dis. 2012. PMID: 22441652

7

Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.

Vellozzi C, Broder KR, Haber P, Guh A, Nguyen M, Cano M, Lewis P, McNeil MM, Bryant M, Singleton J, Martin D, DeStefano F. Vellozzi C, et al. Vaccine. 2010 Oct 21;28(45):7248-55. doi: 10.1016/j.vaccine.2010.09.021. Epub 2010 Sep 16. Vaccine. 2010. PMID: 20850534

8

Sequential surveillance for drug safety in a regulatory environment.

Martin D, Gagne JJ, Gruber S, Izem R, Nelson JC, Nguyen MD, Ouellet-Hellstrom R, Schneeweiss S, Toh S, Walker AM. Martin D, et al. Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):707-712. doi: 10.1002/pds.4407. Epub 2018 Mar 5. Pharmacoepidemiol Drug Saf. 2018. PMID: 29504168 No abstract available.

9

Responding to vaccine safety signals during pandemic influenza: a modeling study.

Maro JC, Fryback DG, Lieu TA, Lee GM, Martin DB. Maro JC, et al. Among authors: martin db. PLoS One. 2014 Dec 23;9(12):e115553. doi: 10.1371/journal.pone.0115553. eCollection 2014. PLoS One. 2014. PMID: 25536228 Free PMC article.

10

Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems.

Bell C, Chakravarty A, Gruber S, Heckbert SR, Levenson M, Martin D, Nelson JC, Pinheiro S, Psaty BM, Reich CG, Schneeweiss S, Shoaibi A, Toh S, Walker AM. Bell C, et al. Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1223-5. doi: 10.1002/pds.3712. Epub 2014 Sep 29. Pharmacoepidemiol Drug Saf. 2014. PMID: 25263307 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page